Our Latest News

November 18th, 2018

TFR Global Are Pleased To Announce Their Appointment As Merlin Biotechnologies’ Approved Brokerage For Their Private Placement Financing

TFR Global are pleased to confirm their appointment by Merlin Biotechnologies as the company’s approved brokerage to over-see their 3 rounds of private placement financing which will start early next year. Merlin Biotechnologies, a Canadian based bio-tech company whose focus is primarily on researching and developing clinically approved medicines, using various strains of marijuana, intend to float on the NYSE in the 3rd quarter of 2019.

Their stage 1 round of financing has been set at a price of U.S. $0.85 per share, with stage 2 set at U.S. $1.05 per share and stage 3 at U.S. $1.25 per share. TFR Global’s appointment will allow them to offer investors Merlin Biotechnologies’ IPO stock, throughout all 3 rounds of the financing at the above pricing, and it is expected that it will take no more than 5 months to complete all of the required allocations.Furthermore, TFR Global will be assisting and over-seeing, if necessary, any potential take-over offers that Merlin Biotechnologies may receive before their scheduled flotation takes place. TFR Global’s extensive presence and client base will allow for investors to acquire these pre-IPO stock allocations in Merlin Biotechnologies at entry level positions of between U.S. $10,000 and U.S. $30,000 per client, depending upon allocation availability.


“We are extremely excited about being able to offer our clients, old and new, this fantastic opportunity with one of Canada’s leading marijuana bio-tech companies. The marijuana sector, particularly the medicinal market, is an extremely exciting investment sector to be involved with and our past experiences have shown us it to be a profitable one too,” said Dennis Tillman, Managing Director with TFR Global. “Also, the ethical side that this sector offers is something that a lot of investors find as much of an appeal as the returns it achieves as the clinical advancements being made are now proving to be of enormous benefit to an ever-growing number of people worldwide,” Dennis Tillman added.

Due to TFR Global’s anticipated investment demand relating to this opportunity they have set up a strategic team of senior personnel to ensure that all allocations are made within the least amount of time possible.

Anyone wanting to know more information should contact TFR Global via [email protected].

TFR Global Market Watch - November 2019

TFR Media Team November 14th, 2019

As TFR specialists predicted back in June, Royal Gold Increases Common Stock Dividend to $1.12 per Share

Monthly markets review - October 2019

TFR Media Team November 7th, 2019

A look back on markets in October when risk appetite picked up amid hopes of progress on trade talks.

Monthly markets review - September 2019

TFR Media Team October 21st, 2019

We review global market developments in September, highlighting the best and worst performing sectors globally.

Quarterly markets review - Q3 2019

TFR Media Team October 5th, 2019

A review of markets in Q3, when economic data pointed to an ongoing slowdown and central banks in the US and Europe eased monetary policy.

Monthly markets review - August 2019

TFR Media Team September 5th, 2019

A look back at markets in August when shares declined and bonds outperformed amid rising concerns over the outlook for growth.

Monthly markets review - July 2019

TFR Media Team August 8th, 2019

A look back at markets in July when shares made a modest advance and all eyes were on the Federal Reserve meeting at the end of the month.

Quarterly markets review - Q2 2019

TFR Media Team July 7th, 2019

A look back at markets in Q2 when shares gained despite ongoing trade tensions.

Monthly markets review - May 2019

TFR Media Team June 6th, 2019

A look back at markets in May when stocks fell as trade tensions ratcheted up.

TFR Global June Press Release - June 2019

TFR Media Team June 1st, 2019

TFR Global Predict The Return Of The Gold ‘Super-Cycle’ And Advise Clients To Buy Royal Gold

TFR Global April Press Release - May 2019

TFR Media Team May 19th, 2019

TFR Global Announce Agreement To Acquire The Assets And Subsidiaries Of A Market-Leading Zurich Based Interdealer Brokerage Firm

Monthly markets review - April 2019

TFR Media Team May 7th, 2019

A look back at markets in April when stocks continued to move higher amid encouraging economic data.

TFR Global April Press Release - April 2019

TFR Media Team April 11th, 2019

We Are Pleased To Announce That August 30th Has Been Confirmed As This Year’s 3rd Date For Our 2019 Seminars.

Quarterly markets review - Q1 2019

TFR Media Team April 4th, 2019

A review of Q1 2019 when equities rebounded, supported by market expectations that the Federal Reserve will not raise interest rates this year.

TFR Global March Press Release - March 2019

TFR Media Team March 11th, 2019

TFR Global Announce Server Updates Now Successfully Completed To Their Online Client Account Portal

Monthly markets review - February 2019

TFR Media Team March 6th, 2019

A look back on markets in February when easing trade tensions helped support equity market gains.

1 2 3

Image Image Image Image Image Image Image Image Image Image Image Image Image Image